UK adopts military technology adapted to diagnose chlamydia:
This article was originally published in Clinica
The UK treasury is giving the Porton Down branch of the Department of Science and Technology Laboratory (Dstl) and the Department of Health £4.6m ($6.6m) to provide hospital labs and clinics with a chlamydia screening device that Dstl has created by adapting existing military technology. The technology, initially designed to track biological warfare agents, will enable the NHS to obtain accurate results within 40 minutes compared with the previous standard of a fortnight, thus saving the NHS "millions", claims Dstl. Chlamydia affects 10% of women aged between 16 and 24.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.